BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34768488)

  • 1. Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: Humanitas's Experience.
    Mangiameli G; Bottoni E; Voulaz E; Cariboni U; Testori A; Crepaldi A; Giudici VM; Morenghi E; Alloisio M
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Center 20-Year Experience in Surgical Treatment of Malignant Pleural Mesothelioma.
    Mangiameli G; Bottoni E; Cariboni U; Ferraroli GM; Morenghi E; Giudici VM; Voulaz E; Alloisio M; Testori A
    J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleurectomy-decortication in malignant pleural mesothelioma: are different surgical techniques associated with different outcomes? Results from a multicentre study.
    Marulli G; Breda C; Fontana P; Ratto GB; Leoncini G; Alloisio M; Infante M; Luzzi L; Paladini P; Oliaro A; Ruffini E; Benvenuti MR; Pariscenti G; Spaggiari L; Casiraghi M; Rusca M; Carbognani P; Ampollini L; Facciolo F; Leuzzi G; Mucilli F; Camplese P; Romanello P; Perissinotto E; Rea F
    Eur J Cardiothorac Surg; 2017 Jul; 52(1):63-69. PubMed ID: 28419212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended Pleurectomy and Decortication for Malignant Pleural Mesothelioma Is an Effective and Safe Cytoreductive Surgery in the Elderly.
    Williams T; Duraid H; Watson S; Durkin A; Todd K; Kindler HL; Vigneswaran WT
    Ann Thorac Surg; 2015 Nov; 100(5):1868-74. PubMed ID: 26319490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine followed by adjuvant chemotherapy in patients with malignant pleural mesothelioma.
    Lang-Lazdunski L; Bille A; Belcher E; Cane P; Landau D; Steele J; Taylor H; Spicer J
    J Thorac Oncol; 2011 Oct; 6(10):1746-52. PubMed ID: 21876457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant pemetrexed plus cisplatin followed by pleurectomy for malignant pleural mesothelioma.
    Hasegawa S; Yokoi K; Okada M; Tanaka F; Shimokawa M; Daimon T; Nakano T
    J Thorac Cardiovasc Surg; 2022 Jun; 163(6):1940-1947.e5. PubMed ID: 34419248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up.
    Minatel E; Trovo M; Polesel J; Baresic T; Bearz A; Franchin G; Gobitti C; Rumeileh IA; Drigo A; Fontana P; Pagan V; Trovo MG
    Lung Cancer; 2014 Jan; 83(1):78-82. PubMed ID: 24216141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma-A Prospective Report.
    Bongiolatti S; Mazzoni F; Salimbene O; Caliman E; Ammatuna C; Comin CE; Antonuzzo L; Voltolini L
    J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended pleurectomy/decortication and hyperthermic intraoperative intrapleural cisplatin perfusion for malignant pleural mesothelioma.
    Okubo K; Ishibashi H; Wakejima R; Baba S; Asakawa A; Seshima H
    JTCVS Open; 2023 Dec; 16():977-986. PubMed ID: 38204668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Intraoperative Hypertonic Glucose Solution Administration on Persistent Air Leak After Extended Pleurectomy/Decortication for Malignant Pleural Mesothelioma: A Retrospective Case-Control Study.
    Testori A; Perroni G; Alloisio M; Voulaz E; Giudici VM; Cariboni U; Bottoni E
    Front Oncol; 2021; 11():767791. PubMed ID: 34926272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience.
    Franceschini D; De Rose F; Cozzi S; Renna I; Franzese C; Di Brina L; Navarria P; D'Agostino GR; Mancosu P; Tomatis S; Scorsetti M
    Clin Lung Cancer; 2020 Jan; 21(1):86-93. PubMed ID: 31563545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.
    Minatel E; Trovo M; Bearz A; Di Maso M; Baresic T; Drigo A; Barresi L; Furlan C; Del Conte A; Bruschi G; Fontana P; Pagan V; Franchin G
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):606-13. PubMed ID: 26281826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality.
    Burt BM; Cameron RB; Mollberg NM; Kosinski AS; Schipper PH; Shrager JB; Vigneswaran WT
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):30-5. PubMed ID: 24726744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma.
    Infante M; Morenghi E; Bottoni E; Zucali P; Rahal D; Morlacchi A; Ascolese AM; De Rose F; Navarria P; Crepaldi A; Testori A; Voulaz E; Errico V; Perrino M; Scorsetti M; Chiti A; Santoro A; Alloisio M
    Eur J Cardiothorac Surg; 2016 Dec; 50(6):1077-1082. PubMed ID: 27330149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended pleurectomy decortication for malignant pleural mesothelioma in the elderly: the need for an inclusive yet selective approach.
    Sharkey AJ; Bilancia R; Tenconi S; Nakas A; Waller DA
    Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):696-702. PubMed ID: 29049744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interim results of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy.
    Ishibashi H; Kobayashi M; Takasaki C; Okubo K
    Gen Thorac Cardiovasc Surg; 2015 Jul; 63(7):395-400. PubMed ID: 25750109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant pleural mesothelioma: Comparison of surgery-based trimodality therapy to medical therapy at two tertiary academic institutions.
    Larose F; Quigley N; Lacasse Y; Martel S; Lang-Lazdunski L
    Lung Cancer; 2021 Jun; 156():151-156. PubMed ID: 33962765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes after lung-sparing surgery for epithelial mesothelioma.
    Breda C; Furia S; Lucchini G; Zaccaria A; Verderi E; Natale G; Lo Giudice F; Cavallin R; Ferronato A; Fontana P
    J Thorac Dis; 2021 Nov; 13(11):6283-6293. PubMed ID: 34992808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.
    Shaikh F; Zauderer MG; von Reibnitz D; Wu AJ; Yorke ED; Foster A; Shi W; Zhang Z; Adusumilli PS; Rosenzweig KE; Krug LM; Rusch VW; Rimner A
    J Thorac Oncol; 2017 Jun; 12(6):993-1000. PubMed ID: 28341225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.
    Lang-Lazdunski L; Bille A; Lal R; Cane P; McLean E; Landau D; Steele J; Spicer J
    J Thorac Oncol; 2012 Apr; 7(4):737-43. PubMed ID: 22425923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.